Literature DB >> 21464369

Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation.

Cathy Paddock1, Betsy L Lytle, Francis C Peterson, Trudy Holyst, Peter J Newman, Brian F Volkman, Debra K Newman.   

Abstract

Immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptors inhibit cellular responsiveness to immunoreceptor tyrosine-based activation motif (ITAM)-linked receptors. Although tyrosine phosphorylation is central to the initiation of both inhibitory ITIM and stimulatory ITAM signaling, the events that regulate receptor phosphorylation are incompletely understood. Previous studies have shown that ITAM tyrosines engage in structure-inducing interactions with the plasma membrane that must be relieved for phosphorylation to occur. Whether ITIM phosphorylation is similarly regulated and the mechanisms responsible for release from plasma membrane interactions to enable phosphorylation, however, have not been defined. PECAM-1 is a dual ITIM-containing receptor that inhibits ITAM-dependent responses in hematopoietic cells. We found that the PECAM-1 cytoplasmic domain is unstructured in an aqueous environment but adopts an α-helical conformation within a localized region on interaction with lipid vesicles that mimic the plasma membrane. The lipid-interacting segment contains the C-terminal ITIM tyrosine and a serine residue that undergo activation-dependent phosphorylation. The N-terminal ITIM is excluded from the lipid-interacting segment, and its phosphorylation is secondary to phosphorylation of the membrane-interacting C-terminal ITIM. On the basis of these findings, we propose a novel model for regulation of inhibitory signaling by ITIM-containing receptors that relies on reversible plasma membrane interactions and sequential ITIM phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464369      PMCID: PMC3112045          DOI: 10.1182/blood-2010-11-317867

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Random coil chemical shifts in acidic 8 M urea: implementation of random coil shift data in NMRView.

Authors:  S Schwarzinger; G J Kroon; T R Foss; P E Wright; H J Dyson
Journal:  J Biomol NMR       Date:  2000-09       Impact factor: 2.835

2.  Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation.

Authors:  Christian M Udell; Lionel A Samayawardhena; Yuko Kawakami; Toshiaki Kawakami; Andrew W B Craig
Journal:  J Biol Chem       Date:  2006-05-26       Impact factor: 5.157

3.  Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.

Authors:  N Ilan; L Cheung; E Pinter; J A Madri
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling.

Authors:  D E Jackson; C M Ward; R Wang; P J Newman
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

6.  Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.

Authors:  Naoko Kogata; Michitaka Masuda; Yuji Kamioka; Akiko Yamagishi; Akira Endo; Masato Okada; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

7.  Phosphorylation, high ionic strength, and calmodulin reverse the binding of MARCKS to phospholipid vesicles.

Authors:  J Kim; T Shishido; X Jiang; A Aderem; S McLaughlin
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

8.  Membrane binding mode of intrinsically disordered cytoplasmic domains of T cell receptor signaling subunits depends on lipid composition.

Authors:  Alexander B Sigalov; Gregory M Hendricks
Journal:  Biochem Biophys Res Commun       Date:  2009-09-04       Impact factor: 3.575

9.  The importance of intrinsic disorder for protein phosphorylation.

Authors:  Lilia M Iakoucheva; Predrag Radivojac; Celeste J Brown; Timothy R O'Connor; Jason G Sikes; Zoran Obradovic; A Keith Dunker
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

10.  Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif.

Authors:  Chenqi Xu; Etienne Gagnon; Matthew E Call; Jason R Schnell; Charles D Schwieters; Christopher V Carman; James J Chou; Kai W Wucherpfennig
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

View more
  20 in total

Review 1.  Juxtamembrane contribution to transmembrane signaling.

Authors:  Wei Deng; Renhao Li
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

2.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

Review 3.  Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31).

Authors:  Panida Lertkiatmongkol; Danying Liao; Heng Mei; Yu Hu; Peter J Newman
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

4.  Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.

Authors:  Wei Deng; Sungyun Cho; Pin-Chuan Su; Bryan W Berger; Renhao Li
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

5.  CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity.

Authors:  Danying Liao; Heng Mei; Yu Hu; Debra K Newman; Peter J Newman
Journal:  Life Sci       Date:  2017-11-06       Impact factor: 5.037

6.  An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis.

Authors:  Stefan L Oliver; Jennifer J Brady; Marvin H Sommer; Mike Reichelt; Phillip Sung; Helen M Blau; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

Review 7.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

8.  Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1).

Authors:  Heng Mei; Jay M Campbell; Cathy M Paddock; Panida Lertkiatmongkol; Michael W Mosesson; Ralph Albrecht; Peter J Newman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

9.  The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function.

Authors:  Debra K Newman; Guoping Fu; Tamara Adams; Weiguo Cui; Vidhyalakshmi Arumugam; Theresa Bluemn; Matthew J Riese
Journal:  Sci Signal       Date:  2016-03-08       Impact factor: 8.192

10.  Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids.

Authors:  Xiaoshan Shi; Yunchen Bi; Wei Yang; Xingdong Guo; Yan Jiang; Chanjuan Wan; Lunyi Li; Yibing Bai; Jun Guo; Yujuan Wang; Xiangjun Chen; Bo Wu; Hongbin Sun; Wanli Liu; Junfeng Wang; Chenqi Xu
Journal:  Nature       Date:  2012-12-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.